We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$780M
AUM Growth
+$171M
Cap. Flow
+$112M
Cap. Flow %
14.34%
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.02M
2
AVGO icon
Broadcom
AVGO
+$6.42M
3
TSM icon
TSMC
TSM
+$6.34M
4
MDC
M.D.C. Holdings, Inc.
MDC
+$6.09M
5
OTEX icon
Open Text
OTEX
+$5.5M

Top Sells

Rank Stock Value
1
FOXA icon
Fox Class A
FOXA
+$9.87M
2
FANG icon
Diamondback Energy
FANG
+$9.52M
3
HD icon
Home Depot
HD
+$7.05M
4
MET icon
MetLife
MET
+$6.8M
5
ACN icon
Accenture
ACN
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 21.53%
2 Consumer Discretionary 17.87%
3 Industrials 15.32%
4 Healthcare 12.76%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MEDP icon
201
Medpace
MEDP
$16.8B
$1.01M 0.13%
+4,220
New +$877K
PDFS icon
202
PDF Solutions
PDFS
$2.13B
$1.01M 0.13%
22,344
+4,159
+23% +$170K
SSD icon
203
Simpson Manufacturing
SSD
$7.98B
$987K 0.13%
+7,129
New +$876K
BRD
204
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
$975K 0.13%
92,770
– –
ESE icon
205
ESCO Technologies
ESE
$8.49B
$962K 0.12%
+9,287
New +$892K
IRM icon
206
Iron Mountain
IRM
$38.2B
$960K 0.12%
16,901
– –
DCBO
207
Docebo
DCBO
$492M
$953K 0.12%
24,159
-8,625
-26% -$312K
SBDS
208
DELISTED
Solo Brands Inc
SBDS
$946K 0.12%
4,176
+1,916
+85% +$476K
INSP icon
209
Inspire Medical Systems
INSP
$1.42B
$944K 0.12%
+2,907
New +$831K
HDSN
210
Hudson Technologies
HDSN
$267M
$941K 0.12%
97,778
+73,550
+304% +$639K
CUE icon
211
Cue Biopharma
CUE
$135M
$939K 0.12%
8,574
– –
LLY icon
212
Eli Lilly
LLY
$1.07T
$938K 0.12%
+2,001
New +$839K
ANGI icon
213
Angi Inc
ANGI
$224M
$934K 0.12%
28,290
+21,932
+345% +$614K
XBI icon
214
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$919K 0.12%
11,049
+3,244
+42% +$271K
FDUS icon
215
Fidus Investment
FDUS
$737M
$907K 0.12%
46,272
+3,718
+9% +$70.5K
UFPI icon
216
UFP Industries
UFPI
$4.97B
$906K 0.12%
9,337
+375
+4% +$31.3K
ASO icon
217
Academy Sports + Outdoors
ASO
$2.89B
$891K 0.11%
16,478
-2,479
-13% -$142K
AMPH icon
218
Amphastar Pharmaceuticals
AMPH
$825M
$885K 0.11%
15,407
+628
+4% +$27.8K
REAX icon
219
Real Brokerage
REAX
$368M
$882K 0.11%
+461,864
New +$614K
IRMD icon
220
iRadimed
IRMD
$1.21B
$882K 0.11%
+18,474
New +$833K
U icon
221
Unity
U
$12.5B
$881K 0.11%
+20,294
New +$650K
ARW icon
222
Arrow Electronics
ARW
$10.9B
$880K 0.11%
6,146
+248
+4% +$30.9K
PRGS icon
223
Progress Software
PRGS
$1.55B
$879K 0.11%
15,134
+9,830
+185% +$559K
ATRO icon
224
Astronics
ATRO
$3.45B
$862K 0.11%
52,096
+34,307
+193% +$470K
TDUP icon
225
ThredUp
TDUP
$736M
$849K 0.11%
347,977
+48,700
+16% +$128K
7 8
9
10 11

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q2 2023 Portfolio in Review

As of Q2 2023, Advisory Research held 517 positions worth $780M, up 28% from $608M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Advisory Research deployed $112M of net new capital in Q2 2023, opening 169 new positions and adding to 169 existing holdings. Its largest new stake was Merck: 79,479 shares worth $9.17M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $7.05M trimmed.

  • Advisory Research's largest Q2 2023 buy was Merck: 79,479 shares worth $9.17M.
  • Advisory Research added most to Broadcom in Q2 2023, an estimated $6.42M increase.
  • Advisory Research's biggest Q2 2023 reduction was Home Depot, cutting an estimated $7.05M.
  • Advisory Research fully exited Fox Class A in Q2 2023, selling an estimated $9.87M.
  • Advisory Research's ten largest holdings make up 17% of its $780M portfolio in Q2 2023.
  • Advisory Research opened 169 new positions and closed 81 in Q2 2023.
  • Advisory Research's portfolio value rose 28% quarter-over-quarter to $780M.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.